Browse every story filed under this topic, curated from trusted publishers around the world.
Axsome Therapeutics’ Auvelity expanded its label to include treating agitation in Alzheimer’s disease patients. It’s just the second FDA-approved drug for this indication, and Axsome’s pill has a safety advantage. The post Axsome Drug’s FDA Approval …
Read full story →
Olympic bronze medalist Alysha Newman was banned for 20 months on Friday for missed drug tests, though track and field …
The Food and Drug Administration (FDA) has named Katherine Szarama to be the acting director of the unit in charge …
Shortly after laying out $75 million upfront for Corstasis Therapeutics and its congestive heart failure edema drug Enbumyst, Esperion Therapeutics …
Amgen will rely on the emergence of its newer products in 2026 to overcome the loss of exclusivity of a …
Okolie’s fight with Tony Yoka was derailed on short notice last week, due to the Briton’s adverse drug-test result
After two years, there was an 87% reduction in death in ALS patients treated with Corcept's dazucorilant compared with those …
The new weight loss drug hasn’t even been formally promoted yet, its CEO says.
Medical marijuana could be the next billion dollar industry.
What You Should Know Weave Bio has expanded its AI-native regulatory platform to support New Drug Application (NDA) submissions, covering …
Mark Cuban has spent more than four years building something the healthcare industry is still figuring out how to respond …
Bristol Myers Squibb’s growth portfolio is offsetting declines in older products as planned, even as star heart drug Camzyos faces …
Avalayn Pharma found strong investor interest in its inhalable drugs in development for two types of pulmonary fibrosis, enabling the …
Rep. Seth Moulton (Mass.) on Wednesday became the latest House Democrat to accuse Defense Secretary Pete Hegseth of war crimes, …
The FDA has proposed excluding semaglutide, tirzepatide and liraglutide from the 503B bulks list, the latest move in a monthslong …
A 'quintuple agonist,' Alector halts it Alzheimer's trial, and more biotech news from The Readout
Federal officials have indicted 10 current and former Mexican officials on charges tied to drug trafficking as part of a …
U.S. prescription drug spending increased 12.7% to $915.2 billion in 2025 and is projected to exceed $1 trillion in 2026, …
A federal judge has struck down North Dakota’s 340B drug pricing law, ruling it unconstitutional and permanently blocking its enforcement. …
You've seen all articles for #drug.
Check back
soon
for new stories.